Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Serum-Mediated Cleavage of Bacillus anthracis Protective Antigen Is a Two-Step Process That Involves a Serum Carboxypeptidase.

Goldman DL, Nieves E, Nakouzi A, Rivera J, Phyu EE, Win TH, Achkar JM, Casadevall A.

mSphere. 2018 Jun 27;3(3). pii: e00091-18. doi: 10.1128/mSphere.00091-18. Print 2018 Jun 27.

2.

Utilization and Clinical Value of Diagnostic Modalities for Tuberculosis in a High HIV Prevalence Setting.

Gati S, Chetty R, Wilson D, Achkar JM.

Am J Trop Med Hyg. 2018 Aug;99(2):317-322. doi: 10.4269/ajtmh.17-0965. Epub 2018 Jun 7.

PMID:
29893198
3.

Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis.

Achkar JM, Prados-Rosales R.

Curr Opin Immunol. 2018 Aug;53:30-37. doi: 10.1016/j.coi.2018.04.004. Epub 2018 Apr 12. Review.

PMID:
29656063
4.

Soluble CD14 as a Diagnostic Biomarker for Smear-Negative HIV-Associated Tuberculosis.

Liu Y, Ndumnego OC, Chen T, Kim RS, Jenny-Avital ER, Ndung'u T, Wilson D, Achkar JM.

Pathogens. 2018 Feb 27;7(1). pii: E26. doi: 10.3390/pathogens7010026.

5.

Multiplexed Nucleic Acid Programmable Protein Arrays.

Yu X, Song L, Petritis B, Bian X, Wang H, Viloria J, Park J, Bui H, Li H, Wang J, Liu L, Yang L, Duan H, McMurray DN, Achkar JM, Magee M, Qiu J, LaBaer J.

Theranostics. 2017 Sep 20;7(16):4057-4070. doi: 10.7150/thno.20151. eCollection 2017.

6.

The Cross-Species Mycobacterial Growth Inhibition Assay (MGIA) Project, 2010-2014.

Brennan MJ, Tanner R, Morris S, Scriba TJ, Achkar JM, Zelmer A, Hokey DA, Izzo A, Sharpe S, Williams A, Penn-Nicholson A, Erasmus M, Stylianou E, Hoft DF, McShane H, Fletcher HA.

Clin Vaccine Immunol. 2017 Sep 5;24(9). pii: e00142-17. doi: 10.1128/CVI.00142-17. Print 2017 Sep. Review.

7.

Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine.

Prados-Rosales R, Carreño L, Cheng T, Blanc C, Weinrick B, Malek A, Lowary TL, Baena A, Joe M, Bai Y, Kalscheuer R, Batista-Gonzalez A, Saavedra NA, Sampedro L, Tomás J, Anguita J, Hung SC, Tripathi A, Xu J, Glatman-Freedman A, Jacobs WR Jr, Chan J, Porcelli SA, Achkar JM, Casadevall A.

PLoS Pathog. 2017 Mar 9;13(3):e1006250. doi: 10.1371/journal.ppat.1006250. eCollection 2017 Mar.

8.

Identification of Antibody Targets for Tuberculosis Serology using High-Density Nucleic Acid Programmable Protein Arrays.

Song L, Wallstrom G, Yu X, Hopper M, Van Duine J, Steel J, Park J, Wiktor P, Kahn P, Brunner A, Wilson D, Jenny-Avital ER, Qiu J, Labaer J, Magee DM, Achkar JM.

Mol Cell Proteomics. 2017 Apr;16(4 suppl 1):S277-S289. doi: 10.1074/mcp.M116.065953. Epub 2017 Feb 21.

9.

Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction.

Chen T, Blanc C, Eder AZ, Prados-Rosales R, Souza AC, Kim RS, Glatman-Freedman A, Joe M, Bai Y, Lowary TL, Tanner R, Brennan MJ, Fletcher HA, McShane H, Casadevall A, Achkar JM.

J Infect Dis. 2016 Jul 15;214(2):300-10. doi: 10.1093/infdis/jiw141. Epub 2016 Apr 7.

10.

Host Protein Biomarkers Identify Active Tuberculosis in HIV Uninfected and Co-infected Individuals.

Achkar JM, Cortes L, Croteau P, Yanofsky C, Mentinova M, Rajotte I, Schirm M, Zhou Y, Junqueira-Kipnis AP, Kasprowicz VO, Larsen M, Allard R, Hunter J, Paramithiotis E.

EBioMedicine. 2015 Jul 30;2(9):1160-8. doi: 10.1016/j.ebiom.2015.07.039. eCollection 2015 Sep.

11.

Clinical and Radiographic Manifestations of Sputum Culture-Negative Pulmonary Tuberculosis.

Nguyen MV, Jenny-Avital ER, Burger S, Leibert EM, Achkar JM.

PLoS One. 2015 Oct 8;10(10):e0140003. doi: 10.1371/journal.pone.0140003. eCollection 2015.

12.

B cells and antibodies in the defense against Mycobacterium tuberculosis infection.

Achkar JM, Chan J, Casadevall A.

Immunol Rev. 2015 Mar;264(1):167-81. doi: 10.1111/imr.12276. Review.

13.

National trends in benign pulmonary resections: association with CT and PET imaging.

Hsu L, Achkar JM, Keller SM, Bailey JJ, Cohen HW, Haramati LB.

Chest. 2015 Feb;147(2):e61-e62. doi: 10.1378/chest.14-2423. No abstract available.

14.

The role of B cells and humoral immunity in Mycobacterium tuberculosis infection.

Chan J, Mehta S, Bharrhan S, Chen Y, Achkar JM, Casadevall A, Flynn J.

Semin Immunol. 2014 Dec;26(6):588-600. doi: 10.1016/j.smim.2014.10.005. Epub 2014 Oct 28. Review.

15.

Role of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis.

Achkar JM, Chan J, Casadevall A.

Cold Spring Harb Perspect Med. 2014 Oct 9;5(3):a018432. doi: 10.1101/cshperspect.a018432. Review.

16.

Mycobacterial membrane vesicles administered systemically in mice induce a protective immune response to surface compartments of Mycobacterium tuberculosis.

Prados-Rosales R, Carreño LJ, Batista-Gonzalez A, Baena A, Venkataswamy MM, Xu J, Yu X, Wallstrom G, Magee DM, LaBaer J, Achkar JM, Jacobs WR Jr, Chan J, Porcelli SA, Casadevall A.

MBio. 2014 Sep 30;5(5):e01921-14. doi: 10.1128/mBio.01921-14.

17.

Antibodies against Mycobacterial proteins as biomarkers for HIV-associated smear-negative tuberculosis.

Siev M, Wilson D, Kainth S, Kasprowicz VO, Feintuch CM, Jenny-Avital ER, Achkar JM.

Clin Vaccine Immunol. 2014 Jun;21(6):791-8. doi: 10.1128/CVI.00805-13. Epub 2014 Mar 26.

18.

Immunogenicity of mycobacterial vesicles in humans: identification of a new tuberculosis antibody biomarker.

Ziegenbalg A, Prados-Rosales R, Jenny-Avital ER, Kim RS, Casadevall A, Achkar JM.

Tuberculosis (Edinb). 2013 Jul;93(4):448-55. doi: 10.1016/j.tube.2013.03.001. Epub 2013 Apr 2.

19.

Antibody-mediated immunity against tuberculosis: implications for vaccine development.

Achkar JM, Casadevall A.

Cell Host Microbe. 2013 Mar 13;13(3):250-62. doi: 10.1016/j.chom.2013.02.009. Review.

20.

Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS Clinical Trials Group Protocol A5253.

Swindells S, Komarow L, Tripathy S, Cain KP, MacGregor RR, Achkar JM, Gupta A, Veloso VG, Asmelash A, Omoz-Oarhe AE, Gengiah S, Lalloo U, Allen R, Shiboski C, Andersen J, Qasba SS, Katzenstein DK; AIDS Clinical Trials Group 5253 Study Team.

Int J Tuberc Lung Dis. 2013 Apr;17(4):532-9. doi: 10.5588/ijtld.12.0737.

21.

Antibody responses to mycobacterial antigens in children with tuberculosis: challenges and potential diagnostic value.

Achkar JM, Ziegenbalg A.

Clin Vaccine Immunol. 2012 Dec;19(12):1898-906. doi: 10.1128/CVI.00501-12. Epub 2012 Oct 24. Review.

22.

Independent association of younger age with hemoptysis in adults with pulmonary tuberculosis.

Achkar JM, Joseph G.

Int J Tuberc Lung Dis. 2012 Jul;16(7):897-902. doi: 10.5588/ijtld.11.0758. Epub 2012 May 7.

23.

Diagnosis and inflammatory response of patients with candiduria.

Helbig S, Achkar JM, Jain N, Wang X, Gialanella P, Levi M, Fries BC.

Mycoses. 2013 Jan;56(1):61-9. doi: 10.1111/j.1439-0507.2012.02201.x. Epub 2012 May 10.

24.

Comparative evaluation of profiles of antibodies to mycobacterial capsular polysaccharides in tuberculosis patients and controls stratified by HIV status.

Yu X, Prados-Rosales R, Jenny-Avital ER, Sosa K, Casadevall A, Achkar JM.

Clin Vaccine Immunol. 2012 Feb;19(2):198-208. doi: 10.1128/CVI.05550-11. Epub 2011 Dec 14.

25.

Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response.

Achkar JM, Jenny-Avital ER.

J Infect Dis. 2011 Nov 15;204 Suppl 4:S1179-86. doi: 10.1093/infdis/jir451. Review.

26.

Adjunctive tests for diagnosis of tuberculosis: serology, ELISPOT for site-specific lymphocytes, urinary lipoarabinomannan, string test, and fine needle aspiration.

Achkar JM, Lawn SD, Moosa MY, Wright CA, Kasprowicz VO.

J Infect Dis. 2011 Nov 15;204 Suppl 4:S1130-41. doi: 10.1093/infdis/jir450. Review.

27.

The tuberculosis and HIV epidemic in South Africa and the KwaZulu-Natal Research Institute for Tuberculosis and HIV.

Kasprowicz VO, Achkar JM, Wilson D.

J Infect Dis. 2011 Nov 15;204 Suppl 4:S1099-101. doi: 10.1093/infdis/jir414. No abstract available.

PMID:
21996691
28.

Correlation between serum and plasma antibody titers to mycobacterial antigens.

Siev M, Yu X, Prados-Rosales R, Martiniuk FT, Casadevall A, Achkar JM.

Clin Vaccine Immunol. 2011 Jan;18(1):173-5. doi: 10.1128/CVI.00325-10. Epub 2010 Nov 3.

29.

Candida infections of the genitourinary tract.

Achkar JM, Fries BC.

Clin Microbiol Rev. 2010 Apr;23(2):253-73. doi: 10.1128/CMR.00076-09. Review.

30.

Antibodies against immunodominant antigens of Mycobacterium tuberculosis in subjects with suspected tuberculosis in the United States compared by HIV status.

Achkar JM, Jenny-Avital E, Yu X, Burger S, Leibert E, Bilder PW, Almo SC, Casadevall A, Laal S.

Clin Vaccine Immunol. 2010 Mar;17(3):384-92. doi: 10.1128/CVI.00503-09. Epub 2010 Jan 13.

31.
32.
33.

Immunological options for the treatment of tuberculosis: evaluation of novel therapeutic approaches.

Achkar JM, Casadevall A, Glatman-Freedman A.

Expert Rev Anti Infect Ther. 2007 Jun;5(3):461-74. Review.

PMID:
17547510
34.

Mycobacterium tuberculosis malate synthase- and MPT51-based serodiagnostic assay as an adjunct to rapid identification of pulmonary tuberculosis.

Achkar JM, Dong Y, Holzman RS, Belisle J, Kourbeti IS, Sherpa T, Condos R, Rom WN, Laal S.

Clin Vaccine Immunol. 2006 Nov;13(11):1291-3.

35.

Genetic analysis of HIV-1 strains in rural eastern Cameroon indicates the evolution of second-generation recombinants to circulating recombinant forms.

Konings FA, Haman GR, Xue Y, Urbanski MM, Hertzmark K, Nanfack A, Achkar JM, Burda ST, Nyambi PN.

J Acquir Immune Defic Syndr. 2006 Jul;42(3):331-41.

PMID:
16639350
36.

Infection with HIV type 1 group M non-B subtypes in individuals living in New York City.

Achkar JM, Burda ST, Konings FA, Urbanski MM, Williams CA, Seifen D, Kahirimbanyi MN, Vogler M, Parta M, Lupatkin HC, Zolla-Pazner S, Nyambi PN.

J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):835-44.

PMID:
15213568
37.

Protease mutations in HIV-1 non-B strains infecting drug-naive villagers in Cameroon.

Konings FA, Zhong P, Agwara M, Agyingi L, Zekeng L, Achkar JM, Ewane L, Saa, Afane Ze E, Kinge T, Nyambi PN.

AIDS Res Hum Retroviruses. 2004 Jan;20(1):105-9.

PMID:
15008125
38.

Combined use of serum and urinary antibody for diagnosis of tuberculosis.

Singh KK, Dong Y, Hinds L, Keen MA, Belisle JT, Zolla-Pazner S, Achkar JM, Nadas AJ, Arora VK, Laal S.

J Infect Dis. 2003 Aug 1;188(3):371-7. Epub 2003 Jul 15.

PMID:
12870118
39.

Polymerase chain reaction-based assay for antibody-mediated neutralization of HIV-1 reveals a population of nonneutralized virus undetected by conventional p24 assay.

Achkar JM, Wang XH, Nyambi P, Gorny MK, Zolla-Pazner S, Bandrés JC.

J Acquir Immune Defic Syndr. 2000 Jul 1;24(3):203-10.

PMID:
10969343

Supplemental Content

Loading ...
Support Center